This program has been pre-approved for 1 HR (General) credit hours, toward aPHR®, aPHRi™, PHR®, PHRca®, SPHR®, GPHR®, PHRi™ and SPHRi™ recertification through HR Certification Institute® (HRCI®).
MHA Health Institute is recognized by SHRM to offer Professional Development Credits (PDCs) for SHRM-CP® or SHRM-SCP® recertification activities. This activity is valid for 1 PDC.
In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and the MHA Health Institute. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Nursing — AXIS Medical Education designates this continuing nursing education activity for 1.0 contact hour each.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
All Other Participants — A certificate of attendance for 1.0 clock hour each will be provided.
Requirements for Credit:
- Attend/participate in the educational activity and review all course materials.
- Complete the CE Declaration form online by 11:59 pm on November 16, 2024. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
- Upon successful completion of the online form, your statement of completion will be presented to you to print.
AXIS Contact Information
For information about the accreditation of this program please contact AXIS at info@axismeded.org.
Disclosure of Relevant Financial Relationships
AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, peer reviewers, and other individuals who are in a position to control the content of this activity to disclose all personal financial relationships they may have in the past 24 months with ineligible companies. An ineligible entity is any organization whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are identified and mitigated prior to initiation of the planning phase for an activity.
AXIS has mitigated and disclosed to learners all relevant financial relationships disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.
The faculty, Kara Murphy, MS, reported no relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months.
The directors, planners, managers, peer reviewers, and relevant staff reported the following financial relationships they have with any ineligible company of any amount during the past 24 months:
Name of Planner/Manager /Peer Reviewer/Staff | Reported Financial Relationship |
Peggy Taylor | Nothing to disclose |
Lacey Bergerhofer | Nothing to disclose |
Sarah M. Willson, MBA, BSN, CHPCA | Nothing to disclose |
Dee Morgillo, M.Ed., CHCP | Nothing to disclose |
Holly M. Hampe, D.Sc., R.N., MHA, MRM | Nothing to disclose |
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For More Information
Contact Peggy Taylor at ptaylor@mhanet.com or 573-893-3700, ext. 1370 with questions.